Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ReBOO: Intragastric Botulinum Toxin A for Obesity in Adolescents
NCT03079557Phase 2Completed
- Sponsor
- St. Olavs University Hospital
- Start
- Mar 2017
- Primary completion
- Apr 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in obesity, sponsored by St. Olavs University Hospital. Started Mar 2017; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
obesity
Beyond the preview
Go deeper on NCT03079557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03079557.